Orchid Pharma Limited (NSE:ORCHPHARMA)
660.05
-4.40 (-0.66%)
Feb 16, 2026, 1:15 PM IST
Orchid Pharma Revenue
Orchid Pharma had revenue of 2.07B INR in the quarter ending December 30, 2025, a decrease of -4.64%. This brings the company's revenue in the last twelve months to 8.11B, down -10.02% year-over-year. In the fiscal year ending March 31, 2025, Orchid Pharma had annual revenue of 9.22B with 12.52% growth.
Revenue (ttm)
8.11B
Revenue Growth
-10.02%
P/S Ratio
4.15
Revenue / Employee
11.02M
Employees
736
Market Cap
33.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 9.22B | 1.03B | 12.52% |
| Mar 31, 2024 | 8.19B | 1.53B | 23.05% |
| Mar 31, 2023 | 6.66B | 1.06B | 19.00% |
| Mar 31, 2022 | 5.60B | 1.09B | 24.33% |
| Mar 31, 2021 | 4.50B | -337.41M | -6.97% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 47.26B |
| Akums Drugs and Pharmaceuticals | 42.60B |
| Aarti Pharmalabs | 18.01B |
| Indoco Remedies | 17.60B |
| Innova Captab | 14.97B |
| Solara Active Pharma Sciences | 12.55B |
| Windlas Biotech | 8.68B |
| RPG Life Sciences | 6.74B |
Orchid Pharma News
- 3 months ago - Orchid Pharma Ltd (BOM:524372) Q2 2026 Earnings Call Highlights: Strategic Acquisitions and ... - GuruFocus
- 3 months ago - Q2 2026 Orchid Pharma Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - Top stocks to buy today: Stock recommendations for July 16, 2025 - check list - The Times of India
- 9 months ago - Orchid Pharma shares drop nearly 5% as Q4 net profit falls 32.4% YoY to Rs 22.3 crore - Business Upturn
- 1 year ago - Orchid Pharma shares surge 4.4% after successful USFDA inspection at Alathur API facility - Business Upturn
- 1 year ago - Orchid Pharma successfully completes USFDA inspection at Alathur API facility, secures EU GMP certification renewal - Business Upturn
- 1 year ago - Orchid Pharma shares drop over 14% as net profit falls 25.63% YoY to ₹22.45 crore in Q3 - Business Upturn
- 1 year ago - Orchid Pharma shares jump nearly 4% following strong Q2 FY25 results - Business Upturn